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Abstract 
Purpose: The modified DUKE-UNC Functional Social Support Questionnaire (FSSQ) 
is considered an assessment tool for patients with schizophrenia. However, it has not 
been validated in this patient population. This issue is addressed here by examining the 
tool’s psychometric properties in a clinical sample of patients with schizophrenia. 
Methods: Two hundred and forty-one patients from 10 Adult Mental Health Centres 
(AMHC) meeting the following inclusion criteria were included: 1) International 
Classification of Diseases-10 (ICD-10) diagnosis of schizophrenia; 2) Global 
Assessment of Functioning (GAF) scores ≤50; 3) Illness duration of more than 2 years; 
and 4) Clinical stability. Patients were evaluated at baseline and at one-year follow-up 
for clinical and psychosocial variables. 
Results: The factor analysis revealed two factors that explained 54.15% of the 
variance. Internal consistency was excellent for the total FSSQ (0.87 at baseline and 
0.88 at one year follow-up) and ranged between adequate and excellent for FSSQ 
domains. Correlations between FSSQ scores and those of global functioning, 
psychiatric symptoms, disability and quality of life ranged between small and large. 
There were significant differences between groups of patients with schizophrenia in 
FSSQ scores. Patients with higher levels of somatic complaints and patients who were 
disabled scored significantly lower in some or all FSSQ scores. After one-year follow-
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up, patients improved in overall functioning and there was a decrease in psychiatric 
symptoms. 
Conclusions: The FSSQ is a reliable and valid instrument for the assessment of 
perceived social support in patients with schizophrenia. 
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Validation of the modified DUKE-UNC Functional Social 
Support Questionnaire in patients with schizophrenia 
1. Introduction 
Social support was conceptualised by Walsh and Connelly (1996) [35] as any material, 
instrumental and emotional support provided by a social network. Such a network 
usually involves family and friends but is not restricted to them [26]. Social networks in 
people with severe mental illness are smaller than those in people without [8, 24] and 
frequently, they are restricted to the immediate family [28]. In patients with severe 
mental illness, poor levels of social support have been associated with poor quality of 
life [31, 41], poor self-esteem [15], high levels of psychiatric symptoms and more 
frequent hospitalisations [10, 33]. 
In view of this relationship between poor social support and poor outcomes in patients 
with severe mental illness, it is important to have specific instruments for assessing 
social support and there are a number of such tools which can be used in this group of 
patients: Social Network and Support Interview Tool [27], Arizona Social Support 
Inventory [3], Multidimensional Scale of Perceived Social Support [43] and Social 
Support Questionnaire [32].    
The modified Duke-UNC Functional Social Support Questionnaire or FSSQ [6] is 
another example of assessment instrument that aims to measure social support. More 
specifically, it aims to measure the person’s satisfaction with the functional and 
affective aspects of his or her social support. It is a brief instrument composed of 11 
items taken from a larger questionnaire that was derived from a literature review [6, 7] 
and includes quantitative and functional measures regarding affective support and 
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confidant support. The FSSQ was developed in English and validated in patients 
recruited from a family medical practice [6]. Further validations have involved patients 
attending primary care health centres [5; 13]. These validation studies have explored the 
factor structure of the FSSQ [5, 6, 13] and have shown the following two factors 1) 
affective support and 2) confidant support. Table 1 summarises the results of these 
studies.  
INSERT TABLE 1 HERE 
The FSSQ is also considered an instrument for use in patients with severe mental illness 
[19] but so far, it has not been validated in this sample population. This issue has been 
addressed here by studying the psychometric properties of the FSSQ in a clinical sample 
of outpatients with schizophrenia. 
Firstly, we aimed to establish its factor structure, its overall internal consistency and the 
internal consistency associated with its domains. Secondly, we addressed FSSQ validity 
evidence: associations with clinical and psychosocial variables, and differences in 
perceived social support between groups of patients with schizophrenia, established 
according to socio-demographic variables, psychiatric symptoms, disability and use of 
services. As in previous studies, we expected to find a positive relationship between 
perceived social support and functioning [12] and quality of life [31, 41] and a negative 
relationship between perceived social support and psychiatric symptoms [10, 33] and 
disability [9]. In the validation study of the FSSQ [6], most socio-demographic 
variables showed no significant associations with perceived social support. We did not 
expect significant differences between groups of patients with schizophrenia based on 
socio-demographic variables. Taking into account the above-mentioned relationships, 
we expected to find differences in perceived social support between groups of patients 
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with schizophrenia, according to psychiatric symptoms and disability. Specifically, we 
expected to find that patients with lower levels of psychiatric symptoms (i.e. depression, 
anxiety and somatic complaints) and lower disability levels would show higher levels of 
perceived social support. We also expected to find differences in perceived social 
support between groups of patients according to use of health services, i.e. that patients 
with lower levels of perceived social support would use health services more frequently 
[5, 6]. In a meta-analysis review, Ziguras & Stuart (2000) [42] showed that community 
treatment programs were effective in patients with severe mental illness in terms of 
clinical and psychosocial outcomes. We expected significant improvements in perceived 
social support, global functioning, psychiatric symptoms, disability and quality of life 
after one year follow-up linked to the effect of community treatment in patients. 
2. Method 
2.1. Sample 
Patients were recruited from 10 Adult Mental Health Centres (AMHC) in Barcelona 
(Spain). AMHC belong to the Catalan Department of Health and provide care to 
patients in a similar way. Multidisciplinary community mental health teams (including  
psychiatrists, psychologists, community mental health nurses and social workers) offer 
a comprehensive intervention to patients with schizophrenia. Such intervention is 
usually managed by a community mental health nurse, provides care at a medical and 
psychosocial level and its intensity depends on patients’ needs. Patient data came from a 
study conducted in these AMHC from December 2006 to January 2008. That study 
consisted of a one-year follow-up of patients in contact with services meeting the 
following inclusion criteria: 1) Global Assessment of Functioning (GAF) [2] scores of 
50 or lower; 2) Illness duration greater than 2 years; 3) International Classification of 
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Diseases-10 (ICD-10) [38] diagnosis of schizophrenia; and 4) Clinical stability at time 
of assessment. The following exclusion criteria were used: dementia, organic brain 
injury or mental retardation. Patients visited consecutively by one of the members of the 
community mental health teams and meeting the study inclusion criteria were asked to 
participate. Two hundred and sixty patients met the inclusion criteria but 19 did not 
consent to take part in the study.  
Details of the clinical and socio-demographic characteristics of the final sample at 
baseline have been described elsewhere [25]. 
Two hundred and nineteen patients (90.9%) were re-evaluated one year after the first 
assessment. Sixteen patients (out of 22) were not evaluated because they were not 
clinically stable at time of assessment or had lost contact with services, 3 died (2 by 
suicide and 1 from terminal illness), 2 did not finish the assessments and 1 left the 
study. 
2.2. Instruments 
Patients were evaluated at baseline and at one year follow-up with the following 
assessment tools: 
-The FSSQ[6]. The FSSQ is composed of 11 items. Each item is rated on a five-point 
Likert Scale, ranging from 1 (“Much less than I would like”) to 5 (“As much as I would 
like”). The higher the score, the better the social support perceived. The FSSQ can be 
interviewer- or self-rated, requires 5 minutes to administer and assesses subjective 
social support in two domains: 1) Confidant support (e.g. “My family and friends visit 
me”; theoretical range: 6-30); and 2) Affective support (e.g. “I get love and affection”; 
theoretical range: 5-25); and provides an overall social support measure (theoretical 
range: 11-55). The FSSQ showed test-retest reliability coefficient of 0.66 and internal 
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consistency, evaluated by means of item-remainder correlations, ranged from 0.50 to 
0.85 [7]. It showed significant correlations with symptoms, emotional functioning and 
activities as measured by the DUKE-UNC Health Profile.  
The FSSQ was translated and validated in Spanish [13] in a sample of patients attending 
a primary care health centre in a socio-economically deprived area. The internal 
consistency for the FFSQ total score was 0.82. Another Spanish validation in a sample 
of patients attending primary care health centres in a less socio-economically deprived 
area [5] showed reliability coefficients of 0.80 and 0.92 for hetero-report and self-
report, respectively. Concurrent validity with other health measures ranged in absolute 
values from 0.13 to 0.81 [5].  
-The Positive and Negative Syndrome Scale or PANSS [21]. This is an instrument used 
to assess the severity of symptoms in patients with schizophrenia and has been 
translated into and validated in Spanish [29]. It includes three domains: positive 
(theoretical range: 7-49 where 49 indicates higher levels of positive psychiatric 
symptoms); negative (theoretical range: 7-49 where 49 denotes higher levels of negative 
psychiatric symptoms); general (theoretical range: 16-112; where 112 represents higher 
levels of general psychiatric symptoms); and provides a measure of psychiatric 
symptoms in general terms (theoretical range: 30-210, where 210 means higher levels of 
psychiatric symptoms). Its subscales showed internal consistency values that ranged 
between medium and high and its convergent validity with other measures of 
psychiatric symptoms was high and ranged from 0.70 to 0.81 [29]. 
-The GAF from the Diagnostic and Statistical Manual of Mental Disorders Fourth 
Edition (DSM-IV) [2] is a reliable and valid instrument to measure global functioning in 
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psychiatric patients. Its theoretical range oscillates between 1 and 100. The higher the 
score, the better the global functioning of patient. 
-The World Health Organization Short Disability Assessment Schedule (DAS-s) [18] 
from the ICD-10 [38]. This is a valid instrument to assess disability composed of seven 
items and developed by the World Health Organization. Its theoretical range is 0-30.  
The higher the score, the higher the patient disability. 
-The World Health Organization Quality of Life Scale Brief Version (WHOQOL-
BREF) [39]. This is a short instrument to assess subjective quality of life that is derived 
from the World Health Organization Quality of Life Scale [39]. It showed internal 
consistency values that ranged between 0.66 and 0.84; correlations with the WHOQOL-
100 subscales ranged from 0.89 to 0.95 [39]. Its translation into Spanish [23] showed 
proper psychometric properties in outpatients suffering from schizophrenia [25]. 
2.3. Procedure 
The Ethics Committee of the Catalan Union of Hospitals approved the study in 
accordance with the ethical standards of the 1964 Declaration of Helsinki. Patients 
provided informed consent after the procedures and assessments had been explained to 
them. 
The AMHC community mental health teams performed the study assessments. Namely, 
the psychiatrists established patient diagnoses by an interview according to the ICD-10 
[38] research diagnosis criteria and self and caregiver reports. 
The psychiatrists also assessed psychiatric symptoms and global functioning, and the 
other members of the community mental health teams conducted the rest of the 
assessments under the psychiatrists’ supervision. The psychiatrists were in charge of 
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setting up the assessment agenda, managing its progress and sending the score sheets to 
the psychologist responsible for the study database. 
Different measures were taken to ensure the quality of assessment data. Firstly, all 
psychiatrists participated in a schizophrenia diagnostic agreement workshop by means 
of two clinical vignettes. Secondly, all researchers received a 4-hour training session on 
the use of assessment instruments run by a psychologist with experience in the 
assessment of psychiatric patients, especially those with psychosis. Moreover, patient 
data were contrasted with data from AMHC and systematic examinations of the coding 
and registration of data were run. 
Patients were evaluated at baseline and at one-year follow-up according to the following 
procedure. First, to check patient inclusion criteria, the psychiatrist assessed global 
functioning and psychiatric symptoms with the GAF and the PANSS respectively. 
Second, the other community mental health team members conducted the other 
assessments in the following order: 1) DAS-s; 2) the WHOQOL-BREF; and 3) the 
FSSQ. Systematic reviews of data coding and registration were run after each 
assessment and patient information was contrasted with data from family interviews and 
data registered in AMHC. 
2.4. Data analysis 
Data were analysed using the Statistical Package for the Social Sciences v.15.  
Exploratory factor analysis (EFA) was performed using principal axis factoring and 
varimax rotation. Factors were selected using the following criteria: 1) the analysis of 
the scree plot, and 2) eigenvalues > 1 [17, 20].  
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Internal consistency was evaluated at baseline and at one-year follow-up by means of 
Cronbach’s α. We studied the contribution of FSSQ items to the overall α, and the α 
associated with their domains. Cronbach’s α coefficients were established as follows: 
0.60≤ α <0.80 adequate; 0.80≤ α <0.85 good; and α ≥0.85 excellent [16]. 
Pearson’s correlations between FSSQ scores at baseline and the GAF, PANSS, DAS-s 
and WHOQOL-BREF scores at baseline were calculated to assess validity evidence [1]. 
We considered the correlation coefficients as follows: 1) <0.3 = small; 2) 0.3 to 0.5 = 
moderate; and 3) ≥0.5 large [11].  
To test differences in FSSQ scores between groups of patients with schizophrenia, we 
used T-tests and analysis of variance test. The groups of patients were classified 
according to socio-demographic variables, the existence of psychiatric symptoms such 
as anxiety [21] (item 2 of PANSS general ≥4), depression [21] (item 6 of  PANSS 
general ≥4) and somatic complaints [21] (item 1 of PANSS general ≥4) and disability 
(DAS-s total mean score ≥4). We considered a cut-off item score of ≥4 for the DAS-s 
since a score of ≥4 indicates disability, although with the presence of external help [18]. 
Groups of patients were also established according to use of health services during the 
year prior to baseline assessment.  
To assess change in patient status between baseline and at one-year follow-up, we used 
T-tests for dependent samples. FSSQ, GAF, PANSS, DAS-s and WHOQOL-BREF 
scores and use of community mental health services (i.e. community psychiatric visits 
and community nursing visits) were considered for those analyses. For community 
mental health services, we compared the frequency of patient visits during the year prior 
to baseline assessment and the frequency of patient visits during the year following that 
assessment. We applied the Bonferroni correction for multiple comparisons [14] and we 
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considered significant a p value ≤0.004. We estimated the effect size [30] which was 
considered as follows: 1) <0.3=small; 2) 0.3 to 0.5=moderate; and 3) ≥0.5 large [11]. 
We calculated differences between scores at baseline and at one-year follow-up for 
FSSQ, GAF, PANSS, DAS-s, WHOQOL-BREF and use of community mental health 
services. Pearson’s correlation coefficients were used to calculate sensitivity to change 
between FSSQ score differences and differences in the rest of the scores. 
3. Results 
3.1. Factor analysis 
The EFA revealed a two-factor structure with eigenvalues greater than 1 which 
explained 54.15% of the variance. Table 2 shows item loading on each factor and the 
explained variance. Factor 1 (Confidant Support) included 6 items relating to the 
possibilities of counting on someone to communicate; factor 2 (Affective Support) 
included 5 items relating to counting on someone for love, care and empathy. Items 
number 3 and 5 had almost identical loadings in factor 1 and 2. Taking their conceptual 
meaning into account, we considered them in Factor 2 for the subsequent analyses. 
INSERT TABLE 2 HERE 
3.2. Internal consistency 
Internal consistency coefficient for FSSQ total score at baseline was 0.87 and 0.88 at 
one-year follow-up. For the FSSQ domains according to Broadhead (1988)[6], 
coefficients were 0.66 for FSSQ affective and 0.83 for FSSQ confidant at baseline, 
while at one year follow-up, they were 0.69 for FSSQ affective and 0.86 for FSSQ 
confidant. We also tested the change in Cronbach's alpha values when items are 
suppressed. Only the suppression of item 2 (i.e. “Chances to talk to someone I trust 
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about my personal and family problems”) increased the level of internal consistency of 
the FSSQ total by 0.002 at baseline. The suppression of any other items maintained or 
decreased internal coefficients by 0.02 maximum, which may be considered negligible. 
Regarding the FSSQ domains, the suppression of item 1 (i.e. “Love and affection”) 
increased internal consistency levels by 0.03 and 0.02 at baseline and at one year 
follow-up, respectively. The suppression of any other items maintained or decreased 
internal coefficients by 0.12 maximum. 
3.3. Validity evidence 
Pearson's correlations between FSSQ scores and GAF, PANSS, DAS-s and WHOQOL-
BREF scores at baseline were mostly significant, and ranged from 0.00 to 0.55 (see 
Table 3). Specifically: correlations between FSSQ and GAF scores were positive and 
small; correlations between FSSQ and PANSS scores were mostly negative and small; 
correlations between FSSQ and DAS-s scores were also negative but moderate; and 
correlations between FSSQ and WHOQOL-BREF scores were positive and ranged 
between small and large. 
Table 3 also shows the differences in FSSQ scores in groups of patients with 
schizophrenia. There were no statistically significant differences in FSSQ scores 
between groups established according to socio-demographic variables. There were 
significant differences between groups of patients with schizophrenia based on levels of 
somatic complaints and levels of disability. In particular, patients with higher levels of 
somatic complaints scored significantly lower in FSSQ total. Patients who were 
disabled scored significantly lower in FSSQ total and FSSQ domain scores. No other 
differences were observed.  
INSERT TABLE 3 HERE 
 14
3.4. Changes over time 
FSSQ scores remained about the same over time. There were statistically significant 
changes over time regarding all PANSS and GAF scores. There was a decrease in 
psychiatric symptoms as revealed by changes in PANSS scores over time and an 
improvement in overall functioning as shown by changes in GAF scores over time. 
Effect sizes were medium for most scores but small for GAF social scores. DAS-s 
scores decreased over time but not significantly and WHOQOL-BREF scores remained 
the same over time. With regard to use of health services, there were statistically 
significant changes over time in community nursing visits. Specifically, there was an 
increase in community nursing visits with a small effect size. No other statistically 
significant differences over time were observed (See Table 4). 
INSERT TABLE 4 HERE 
3.5. Sensitivity to change 
Firstly, score differences between baseline and one-year follow-up were calculated for 
FSSQ scores, the other assessment instruments and community service visits. Secondly, 
Pearson's correlation coefficients between FSSQ score differences and all other score 
differences were calculated (see Table 5): Pearson's correlations between changes in 
FSSQ scores and changes in GAF were non-significant; Pearson's correlations between 
changes in FSSQ scores and changes in PANSS general and total scores were 
significant except for FSSQ affective scores; Pearson’s correlations between changes in 
FSSQ scores and changes in DAS-s and WHOQOL-BREF scores were all significant; 
and Pearson’s correlations between changes in FSSQ scores and community service 
visits were non-significant. Those coefficients ranged from -0.01 to 0.36. In particular: 
correlations between the change in FSSQ and the change in GAF scores were positive 
 15
and small; correlations between changes in FSSQ and changes in PANSS and DAS-s 
scores were mostly negative and small; correlations between changes in FSSQ and 
changes in WHOQOL-BREF scores were positive and ranged between small and 
moderate. As for use of health services, correlations were mostly negative and small.  
INSERT TABLE 5 ABOUT HERE 
4. Discussion  
The aim of this study was to validate the FSSQ in patients with schizophrenia. The 
FSSQ showed suitable psychometric properties in this patient population. 
The EFA of the FSSQ revealed the existence of two factors, Confidant Social Support 
and Affective Social Support, that gather information regarding the possibilities of 
counting on someone for communication and the possibilities of counting on someone 
for love, care and empathy, respectively. This factor structure is similar to that observed 
in other studies [5, 6; 13] in which items 6, 7, 8 and 10 load in the same factor 1, and 
item 5 loads in factor 2. Item 3 also loads in factor 2 in the studies conducted by de la 
Revilla Ahumada (1991) [13] and Bellón Saameño (1996) [5] and their results are 
consistent with ours.  Items 1 and 11 loaded in Factor 1 and 2 respectively [5, 13], while 
in our study it was the other way around. The differences regarding the loadings of 
items 1 and 11 across studies may be explained by differences in perceptions between 
patients with schizophrenia and other informants [34, 36, 40]. The loading of items 2, 4 
and 9 in factor 2 is only consistent with the factor structure of de la Revilla Ahumada 
(1991) [13] which, in fact, is the most similar to that shown in the present study except 
for items 1 and 11. This could be related to similarities in the characteristics of the 
samples included. De la Revilla Ahumada (1991) [13] included patients from primary 
care services with a low socio-economical status, which might be similar to the status of 
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patients included in our sample and the deprived socio-economic situation of patients 
with schizophrenia [22]. 
Internal consistency values at baseline and at one year follow-up were excellent. With 
regard to FSSQ domains, the FSSQ confidant showed good internal consistency at 
baseline and excellent at one year follow-up. The FSSQ affective showed appropriate 
internal consistency values both at baseline and at one year follow-up. In the study 
validation of the FSSQ [6], the internal consistency value of the FSSQ affective was 
0.64, which is very similar to that observed in the present study (i.e. 0.66 at baseline and 
0.69 at one year follow-up). Even so, the internal consistency value for FSSQ confidant 
was 0.62, which is lower than that observed in the present study (i.e. 0.83 and 0.86). 
This could be related to differences in the samples included in the two studies. Other 
studies that deal with the psychometric properties of the FSSQ domains show similar 
results to ours. For example, Bellón Saameño [5] showed  internal consistency values 
for affective FSSQ and confidant FSSQ of 0.79 and 0.88, respectively. The internal 
consistency values observed in this study for the total FSSQ are also in agreement with 
the body of evidence regarding the psychometric properties of the FSSQ. For example, 
de la Revilla Ahumada [13] and Bellón Saameño [5] showed internal consistency values 
for the total FSSQ of 0.81 and 0.90 respectively.   
We expected to find that perceived social support had a positive relationship with 
functioning [12] and quality of life [31, 41], while the severity of symptoms [10, 33] 
and disability [9] would have a negative one. Those were the directional relationships 
observed. It is relevant to highlight that the correlation coefficients of perceived social 
support with those variables ranged between small and large, with disability and quality 
of life showing the largest coefficients. This might suggest that disability and quality of 
life are more closely related to perceived social support than psychiatric symptoms and 
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global functioning. It should be also emphasised that psychiatric symptoms and 
functioning were assessed by clinicians, while perceived social support and quality of 
life were self-rated. Again, it seems that the results may reflect differences between the 
perceptions made by patients with schizophrenia and other informants [34, 36, 40]. 
Therefore, the highest correlations might have been observed for those measures 
provided by the same informant as is shown in other studies [4]. 
There were no differences in FSSQ scores between groups of patients with 
schizophrenia established according to socio-demographic variables. Our results are, in 
general terms, consistent with the results of the validation study of the FSSQ [6]. In this 
study, most of the socio-demographic variables included (i.e. gender, marital status, 
employment status, age, education and socio-economic status)  did not show significant 
associations with FSSQ domains except for race, which was associated with confidant 
support, and living situation, which was associated with both FSSQ domains. We did 
not include race in our study since 100% of the sample was Caucasian and the lack of 
association between employment and FSSQ domains could be explained by sample 
differences between our study and the study conducted by Broadhead [6]. While in our 
study the sample included outpatients with diagnosis of schizophrenia, the study 
conducted by Broadhead [6] included patients attending a family medical practice. Even 
so, McFarlane [26] showed that four out of five social support measures were not 
associated with employment status. McFarlane [26] also observed a similar trend for 
education, which is also consistent with our results. 
There were significant differences between groups of patients with schizophrenia 
according to clinical and psychosocial variables. Patients who had higher levels of 
somatic complaints and patients who were disabled showed poorer levels of perceived 
social support in almost all FSSQ scores. Bellón Saameño [5] also showed similar 
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associations between perceived social support and psychosomatic symptoms and 
Cechnicki [9] between the former and disability. As for psychiatric symptoms, a body 
of evidence supports negative associations between perceived social support and 
psychiatric symptoms in general terms [10, 33]. This has only been observed to a 
certain extent in our study since depressed and anxious patients did not show lower 
levels of social support and only patients with somatic complaints scored lower in the 
overall measure of perceived social support. Group differences may not be wholly 
accurate since they were made according to cut-offs of single instrument items rather 
than through diagnostic interviews, which may explain our results. Broadhead (1988) 
[6] described lower levels of social support for patients with higher levels of health 
service use, but no association can be seen in the present study. Specifically, patients 
who used primary care services and social care services did not show lower levels of 
social support. This might be related to the fact that all patients received services from 
community treatment programmes, which have been shown to decrease use of services 
in patients with severe mental illness [42].  
At one-year follow-up, as a consequence of the role of AMHC in the provision of care 
to patients with schizophrenia, we expected an increase in levels of social support, 
global functioning and quality of life and a decrease in levels of psychiatric symptoms 
and disability. There were only improvements in psychiatric symptoms and global 
functioning along with a rise of the frequency of visits to community psychiatric nurses. 
We observed a decrease in disability, although non-significant, and we did not observe 
improvements regarding social support and quality of life as perceived by patients. This 
might somehow reflect the need for more specific psychosocial interventions aimed at 
improving social support and quality of life and decreasing disability [37]. The lack of 
changes in FSSQ scores at one year follow-up might be one of the reasons for the 
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mainly small significant associations between changes in FSSQ scores from baseline to 
one year follow-up and changes in the rest of the test scores, and AMHC visits between 
baseline and one year follow-up.  
The FSSQ has been considered for the assessment of patients with schizophrenia 
although it has yet to be validated. The present findings provide evidence regarding the 
psychometric properties of the FSSQ in patients with schizophrenia which supports its 
use in this patient population. It shows that the FSSQ is reliable and valid, and that it 
could be used for the assessment of perceived social support in patients with 
schizophrenia for research or clinical practice purposes. Further studies should involve 
psychometric properties in other samples, such as other mental disorders, as well as 
other populations.  
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Table 1. Results of the studies including exploratory factor analyses regarding the FSSQ1 
Authors  Sample Setting Factors  Internal consistency Items in each factor 
Broadhead (1988) 401 patients  Family medicine practice F1: Confidant Support 
F2: Affective Support  






De La Revilla Ahumada (1991) 139 patients Health centre in a socio-economically deprived area F1: Confidant Support  




Bellón-Saameño (1996) 656 patients Urban health centre F1: Confidant Support  





a: Average item reminder correlations; b: Overall Cronbach’s α coefficient of the FSSQ; c:  Cronbach’s α coefficient of the FSSQ domains 
1. FSSQ: The modified DUKE-UNC Functional Social Support Questionnaire 
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Items FACTOR 1 FACTOR 2 
1 0.025 0.871 
2 0.226 0.502 
3 0.431 0.455 
4 0.736 0.208 
5 0.500 0.480 
6 0.781 0.221 
7 0.827 0.139 
8 0.733 0.227 
9 0.220 0.629 
10 0.722 0.255 
11 0.646 0.197 
Explained variance (%) 43.85 10.30 
Measure of sampling adequacy 0.90 
Bartlett's test of sphericity (χ
2
; p) (967.64 ; p < 0.001) 
Cronbach’s alpha 0.87 0.68 
Items in factors highlighted in italics 
1. FSSQ: The modified DUKE-UNC Functional Social Support Questionnaire 
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Association with clinical and psychosocial variables [r (p value)] (n=241) 
GAF2-clinical 0.14 (p=0.037) 0.10 (p=0.144) 0.11 (p=0.080) 
GAF-social 0.14 (p=0.032) 0.14 (p=0.027) 0.10 (p=0.132) 
PANSS3 positive -0.09 (p=0.147) -0.03 (p=0.684) -0.11 (p=0.101) 
PANSS negative 0.06 (p=0.327) 0.03 (p=0.679) 0.13 (p=0.048) 
PANSS general -0.07 (p=0.293) -0.05 (p=0.426) -0.02 (p=0.752) 
PANSS total -0.05 (p=0.486) -0.03 (p=0.664) 0.00 (p=0.975) 
DAS-s3 -0.36 (p<0.001) -0.32 (p<0.001) -0.31 (p<0.001) 
WHOQOL-BREF4 physical 0.35 (p<0.001) 0.34 (p<0.001) 0.25 (p<0.001) 
WHOQOL-BREF psychological 0.35 (p<0.001) 0.34 (p<0.001) 0.29 (p<0.001) 
WHOQOL-BREF social relations 0.55 (p<0.001) 0.53 (p<0.001) 0.41 (p<0.001) 
WHOQOL-BREF environment 0.51 (p<0.001) 0.49 (p<0.001) 0.40 (p<0.001) 
WHOQOL-BREF total 0.52 (p<0.001) 0.50 (p<0.001) 0.42 (p<0.001) 
Group differences  [t test(p value)] (n=241) 
Age (≤42years old:>42 years old) 1.24 (p=0.218) 1.42 (p=0.158) 1.18 (p=0.239) 
Gender (male:female) 0.16 (p=0.875) 1.00 (p=0.316) -0.04 (p=0.971) 
Illness duration (≤10 years:>10 years) -1.41 (p=0.162) -1.62 (p=0.108) -1.21 (p=0.230) 
Education (≤ primary school: >primary school) -1.41 (p=0.161) -1.57 (p=0.118) -1.04 (p=0.300) 
Employment status (active: non active) 0.26 (p=0.799) 0.33 (p=0.741) -0.17 (p=0.868) 
Diagnosis (paranoid schizophrenia: other schizophrenias) 1.19 (p=0.234) 1.21 (p=0.230) 0.97 (p=0.331) 
Living arrangement  (family property: others) 1.29 (p=0.198) 0.20 (p=0.840) 2.34 (p=0.020) 
[F (p value)]    
Marital status (single: married or living with partner: divorced or separated or widowed) 0.83 (p=0.438) 1.13 (p=0.325) 0.55 (p=0.581) 
 [t test (p value)]    
Depressed vs. non depressed (PANSS general: item number 6 ≥ 4 vs. item number 6 < 4) 0.31 (p=0.754) 0.33 (p=0.746) 0.42 (p=0.673) 
Anxious vs. no anxious (PANSS general: item number 2 ≥ 4 vs. item number 2 < 4) -0.97 (p=0.336) -0.13 (p=0.897) -1.17 (p=0.249) 
Somatic complaints vs. no somatic complaints (PANSS general: item 1 ≥ 4 vs. item number 1 < 4) 2.88 (p=0.004) 2.46 (p=0.015) 1.86 (p=0.064) 
Disabled vs. non disabled (DAS-s ≥ 4 vs. DAS-s < 4) 4.78 (p<0.001)  4.47 (p<0.001) 4.39 (p<0.001) 
Use of general practitioner services vs. no use of general practitioner servicesϒ  0.41 (p=0.683) 1.01 (p=0.316) 0.36 (p=0.722) 
Use of primary care nurse services vs. no use of primary care nurse servicesϒ -0.13 (p=0.898) 0.93 (p=0.356) -0.45 (p=0.657) 
Use of social services vs. no use of social servicesϒ -2.09 (p=0.037) -1.17 (p=0.244) -2.40 (p=0.017) 
n=sample size at baseline  
1.  FSSQ: The modified DUKE-UNC Functional Social Support Questionnaire; 2.GAF: Global Assessment of Functioning; 3.PANSS: Positive and Negative Syndrome Scale; 3. DAS-s: The World Health Organization 
Short Disability Assessment Schedule; 4. WHOQOL-BREF: World Health Organization Quality of Life Brief Version  
ϒ: Time frame : patient visits during the year prior to the first assessment versus patients visits during the year after the first assessment 
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Table 4. Clinical and psychosocial variables and use of health services at baseline and at one year follow-up (n=219) 
 
 
Measure Baseline 1 year follow-up Differences over time 
 Mean SD Mean SD t p ES 
FSSQ1 total social support 36.68 9.47 36.57 9.72 0.22 0.823 0.02 
FSSQ  confidant support 16.55 4.99 16.37 5.17 0.63 0.531 0.00 
FSSQ  affective support 10.90 3.14 10.78 3.22 0.68 0.500 0.00 
PANSS2 positive 16.67 6.26 15.22 6.10 5.02 <0.001 0.32 
PANSS  negative 24.07 6.99 22.34 6.90 5.08 <0.001 0.33 
PANSS  general 42.35 12.73 39.22 12.30 5.30 <0.001 0.34 
PANSS  total 83.10 22.47 76.79 21.96 6.14 <0.001 0.38 
GAF3 clinic 47.07 9.69 49.58 11.01 -4.94 <0.001 0.32 
GAF social 44.29 10.00 46.26 10.36 -3.45 <0.001 0.23 
DAS-s4 9.09 4.46 8.59 4.46 2.37 0.018 0.16 
WHOQOL-BREF5 physical health 13.25 2.42 13.27 2.54 -0.95 0.924 0.01 
WHOQOL-BREF psychological health 12.18 2.86 12.19 2.81 -0.01 0.990 0.00 
WHOQOL-BREF social relationships 10.54 3.26 10.50 3.24 0.23 0.816 0.02 
WHOQOL-BREF environment 13.24 2.26 13.31 2.36 -0.51 0.612 0.04 
WHOQOL-BREF general 81.82 13.94 81.95 14.11 -0.18 0.856 0.01 
Community psychiatric visitsϒ 5.76 4.22 6.28 4.43 -1.75 0.082 0.12 
Community nursing visitsϒ 5.92 7.13 8.38 9.03 -4.35 <0.001 0.28 
 
1. FSSQ: The modified DUKE-UNC Functional Social Support Questionnaire; 2. PANSS: Positive and Negative Syndrome Scale; 3. GAF: Global Assessment of Functioning; 4. DAS-s: The 
World Health Organization Short Disability Assessment Schedule; 5. WHOQOL-BREF: World Health Organization Quality of Life Scale Brief Version.  
 
SD: standard deviation; ϒ: Time frame: patient visits during the year prior to the first assessment versus patient visits during the year after the first assessment 
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Table 5. Sensitivity to change of the FSSQ
1










Sensitivity to change     
GAF2 clinical 0.08 (p=0.218) 0.09 (p=0.168) 0.04 (p=0.608) 
GAF social 0.09 (p=0.183) 0.12 (p=0.066) 0.02 (p=0.793) 
PANSS3 positive -0.06 (p=0.364) -0.08 (p=0.250) 0.05 (p=0.449) 
PANSS negative -0.09 (p=0.187) -0.10 (p=0.140) -0.03 (p=0.654) 
PANSS general -0.15 (p=0.024) -0.16 (p=0.019) 0.01 (p=0.880) 
PANSS total -0.13 (p=0.047) -0.15 (p=0.030) 0.01 (p=0.880) 
DAS4-s -0.17 (p=0.015) -0.13 (p=0.050) -0.15 (p=0.028) 
WHOQOL-BREF5 physical 0.24 (p<0.001) 0.25 (p<0.001)  0.17 (p=0.014) 
WHOQOL-BREF psychological 0.27 (p<0.001) 0.27 (p<0.001) 0.21 (p=0.002) 
WHOQOL-BREF social relations 0.28 (p<0.001) 0.31 (p<0.001) 0.07 (p=0.299) 
WHOQOL-BREF environment 0.27 (p<0.001) 0.26 (p<0.001) 0.21 (p=0.002) 
WHOQOL-BREF total 0.36 (p<0.001) 0.36 (p<0.001) 0.25 (p<0.001) 
Community nursing visits (n=218)
ϒ
 0.06 (p=0.363) -0.01 (p=0.922) 0.10 (p=0.157) 
Community psychiatric visits (n=218)
ϒ
 -0.10 (p=0.158) -0.09 (p=0.203) -0.12 (p=0.080) 
n = sample size  
1. FSSQ: The modified DUKE-UNC Functional Social Support Questionnaire; 2.GAF: Global Assessment of Functioning; 3. PANSS: Positive and Negative Syndrome Scale; 4. DAS-s: The 
World Health Organization Short Disability Assessment Schedule; 5. WHOQOL-BREF: World Health Organization Quality of Life Brief Version  
ϒ. Time frame: patient visits during the year after the first assessment vs. patient visits during the year after the second assessment. 
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